Protected: PBS listing of Darzalex® SC to cut treatment time from hours to minutes
This content is password-protected. To view it, please enter the password below. Password:
Browsing: Industry Spotlight
Protected: Low dose rate brachytherapy for localised carcinoma of the prostate
This content is password-protected. To view it, please enter the password below. Password:
Breast cancer breakthrough: GenesisCare launches Australian-first breast cancer biomarker test
GenesisCare is announcing that for the first time, Australian women with non-invasive breast cancer will…
Protected: In-office transperineal prostate biopsy
This content is password-protected. To view it, please enter the password below. Password:
Not All Prostate Cancer is the Same
In today’s special episode of The Oncology Podcast, our Host Rachael Babin chats to Professor…
Lutetium-177 PSMA radioligand therapy shows promise in metastatic castration-resistant prostate cancer
Radioligand therapy, using targeted prostate-specific membrane antigen (PSMA) compounds, is emerging as a promising treatment…
Protected: Novel triplet therapy for newly diagnosed multiple myeloma patients now PBS listed
This content is password-protected. To view it, please enter the password below. Password:
Protected: PBS listing for BRAFTOVI® (encorafenib) + MEKTOVI® (binimetinib) combination therapy for adults with unresectable malignant BRAF-mutant melanoma [1]
This content is password-protected. To view it, please enter the password below. Password:
Protected: Neoadjuvant treatment key to unlocking benefits of PBS-listed Kadcyla® (trastuzumab emtansine) in the adjuvant setting
This content is password-protected. To view it, please enter the password below. Password:
Protected: TECENTRIQ® (atezolizumab) first immunotherapy to be reimbursed for 1L treatment of extensive-stage small cell lung cancer
This content is password-protected. To view it, please enter the password below. Password: